ICD-10 Coding for Benzodiazepine Use Disorder(F13.10, F13.10U, F13.20)
Learn about ICD-10 coding for benzodiazepine use disorders, including dependence (F13.20) and withdrawal (F13.23). Ensure accurate documentation and compliance.
Complete code families applicable to Benzodiazepine Use Disorder
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| F13.20 | Sedative, hypnotic or anxiolytic dependence, uncomplicated | Use when the patient meets criteria for dependence without complications. |
|
| F13.23 | Sedative, hypnotic or anxiolytic withdrawal | Use when withdrawal symptoms are present following cessation or reduction. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBenzodiazepine Use Disorder
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Benzodiazepine Use Disorder.
Vague documentation of substance use
Impact
Clinical: Inadequate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Use specific drug names., Document DSM-5 criteria.
Using F13.10 for dependence cases
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure DSM-5 criteria for dependence are documented and use F13.20.
Incorrect code usage
Impact
Using abuse codes for dependence cases.
Mitigation
Train staff on DSM-5 criteria and proper code selection.